Access Digital Health
CountriesInterventionsToolsAbout
Log in
← Interventions

Seasonal malaria chemoprevention (SMC)

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
see below
no $/DALY source
GiveWell
12.8×
cash multiple
CE sources
1
Tier A · 0 studies
Source agreement
—
single source
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

GiveWell program model (× cash)Tier A · program model
Malaria Consortium · seasonal malaria 2025
Geography× cashlives / M$ / lifegrant
Kebbi, Nigeria61.51,535$652$1.0M
Sokoto, Nigeria56.01,409$710$1.0M
Borno, Nigeria55.51,196$836$1.0M

GiveWell’s published mortality & grant figures per geography. Click any × cash value for full provenance and GiveWell’s own DALY-approx.

Focus a geography

Different framework — not comparable to the $/DALY axis. Native unit is multiples of cash transfers.

Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is not currently shown. The country health-system view — workforce density, financing mix, service coverage — is being rebuilt as part of the scenario layer. The underlying indicators remain in the country pages.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for Seasonal malaria chemoprevention (SMC)? Select a country above, then open its intelligence page.